HOME : Support : Dialog Search Aids : Bluesheets
RSS FeedAdd RSS | What is RSS?
View Bluesheets by | Database Name | File Number | Subject | OneSearch Categories | Search Options |
45
EMCare®

Last Loaded on Web: Thursday, May 01, 2008

Last Update To Bluesheet: August 29, 2007

Bluesheet Contents     PDF version

File Description Print Counterparts Geographic Coverage Terms and Conditions Limit Rates
Subject Coverage Dialog File Data Special Features Sample Record Sort
Sources Related Search Aids DIALINDEX/OneSearch Categories Basic Index Rank
Tips Document Types Indexed Contact Additional Indexes Predefined Format Options


File Description [top]

EMCare is Elsevier's new database on all nursing specialities and healthcare professions. EMCare includes coverage of allied health, education and training, development and management, midwifery, health and health care economics, clinical medical and health care social work, psychiatry and mental health, and traumatology, critical care medicine. All specialities of nursing are covered, including (but not limited to) addictions nursing, coronary care, flight nursing, hospice and palliative care, neonatal nursing, occupational health, perioperative nursing, psychiatric nursing, school health nursing, urologic nursing, burn nursing, community and mental health, gastroenterology nursing, gynaecologic nursing, HIV/AIDS nursing, professional home nursing, medical-surgical nursing, obstetric nursing, paediatric nursing, respiratory nursing and plastic surgical nursing.

The database provides the full author abstract for about 75% of articles in all, and about 85% of current articles. Articles are indexed with EMTREE terms from Elsevier's Life Science Thesaurus, which has been comprehensively expanded with nursing terms. Articles are indexed within 15 days of receipt and are online very soon after that. Both trade journals and electronic-only journals from around the world are included.



Tips [top]

USE EXPLODE(!)

to retrieve all narrower descriptors:

     S PHARMACOGENETICS!

USE THE ONLINE THESAURUS

to find EMTREE preferred terms:

     E (ULCER)

USE TN AND MN

to find manufacturer and trade names in relevant records

     S TN=BAYER



Subject Coverage [top]

EMCare covers all specialties of nursing, including:

  • addictions nursing
  • coronary care
  • flight nursing
  • hospice and palliative care
  • neonatal nursing
  • occupational health
  • periperative nursing
  • psychiatric nursing
  • school health nursing
  • urologic nursing
  • burn nursing
  • community and mental health
  • gastroenterology nursing
  • gynaecologic nursing
  • HIV/AIDS nursing
  • professional home nursing
  • medical-surgical nursing
  • obstetric nursing
  • paediatric nursing
  • respiratory nursing
  • plastic surgical nursing
  • and more


Sources [top]

EMCare has about 2,700 currently published journals and a further 900 relevant ceased titles. A little more than half of the journals are shared with EMBASE. Relevant coverage from MEDLINE is included, and about 67% of CINahl's journals are included in EMCare.



Print Counterparts [top]

  • Excerpta Medica Abstract Journals


Dialog File Data [top]

Dates Covered: 1995 to the present
File Size: Approx. 2 million records as of July 2006
Update Frequency: Weekly


Related Search Aids [top]

The following search aids are available in the Dialog Library:



Document Types Indexed [top]

  • Journal Articles


Geographic Coverage [top]

  • International


Geographic Restrictions [top]

  • None


Special Features [top]


DialIndex/OneSearch Categories [top]

ACRONYM CATEGORY NAME
ALTMED Alternative Medicine
BIOCHEM Biochemistry
BIOSCI Biosciences
BIOTECH Biotechnology
BRANDNMS Brand Names
HEALTH Health
MEDDEV Medical Devices
MEDICINE Medicine
NURSING Nursing and Health Administration
PHARM Pharmacology
SAFETY Safety


Contact [top]

EMCare is provided by Elsevier B.V. Questions concerning file content should be directed to:

Elsevier B.V.
P.O. Box 211
Amsterdam, 1000 AE
The Netherlands
Telephone: +31-20-485-3507
Fax: +31-20-485-3432
E-Mail: ebd-marketing@elsevier.com


Terms and Conditions [top]

For Dialog's Redistribution and Archive Policy, enter HELP ERA online. Note, however, that EMCARE has a separate Archive policy and data may only be held in electronic form for a maximum period of 12 months from the date it is first downloaded and must then be deleted. Those customers that want to archive beyond 12 months should contact their Account Manager or nearest Customer Services desk to obtain an extended archiving license. The following terms and conditions also apply.

The database is owned and copyrighted by Elsevier B.V. NEITHER ELSEVIER NOR ANY OF ITS AFFILIATES OR LICENSORS SHALL BE LIABLE TO YOU OR ANYONE ELSE FOR ANY LOSS OR INJURY, CAUSED IN WHOLE OR PART BY ITS NEGLIGENCE OR CONTINGENCIES BEYOND ITS CONTROL IN PROCURING, COMPILING, INTERPRETING, REPORTING, OR DELIVERING INFORMATION THROUGH THE SITE. IN NO EVENT WILL ELSEVIER, ITS AFFILIATES OR LICENSORS BE LIABLE TO YOU OR ANYONE ELSE FOR ANY DECISION MADE OR ACTION TAKEN BY YOU IN RELIANCE ON SUCH INFORMATION. ELSEVIER AND ITS AFFILIATES AND LICENSORS SHALL NOT BE LIABLE TO YOU OR ANYONE ELSE FOR ANY DAMAGES (INCLUDING, WITHOUT LIMITATION, CONSEQUENTIAL, SPECIAL, INCIDENTAL, INDIRECT, OR SIMILAR DAMAGES) EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

Elsevier neither endorses nor takes responsibility for any products, goods or services offered by outside vendors through our services or advertised on our system.


Dialog Standard Terms & Conditions apply.


SAMPLE RECORD [top]

    DIALOG(R)File 45:EMCare 
    (c) 2006 Elsevier B.V. All rts. reserv. 
     
  AA=  01885423     EMCare No: 43731839 
  /TI    Designer steroids: Past, present and future 
  AU=    Fourcroy J. 
  CS=    J. Fourcroy, 6310 Swords Way, Bethesda, MD 20817  United States 
      AUTHOR EMAIL: Fourcroy@aol.com 
  JN=,CP=,PY=,SO=    Current Opinion in Endocrinology and Diabetes ( CURR. OPIN. ENDOCRINOL. 
      DIABETES ) (United States)   2006, 13/3 (306-309) 
  CD=,SN=    CODEN: CENDE   ISSN: 1068-3097 
  II=    PUBLISHER ITEM IDENTIFIER: 0006079320060600000012 
  DT=    DOCUMENT TYPE: Journal ; Review 
  LA=,SL=    LANGUAGE: ENGLISH   SUMMARY LANGUAGE: ENGLISH 
      NUMBER OF REFERENCES: 37 
  RT=    RECORD TYPE: Abstract 
     
  /AB    Purpose of review: Current therapy and future drug development depend on 
    an understanding of the developmental and regulatory history of androgenic 
    anabolic steroids. After 1962, multiple regulatory changes altered the 
    availability of many of these compounds and added the need to demonstrate 
    both safety and efficacy for this class of drugs. The athletic community 
    first recognized the anabolic effect of androgenic anabolic steroids and 
    used a multitude of these compounds for 'doping'. What followed was an 
    illicit market and the development of new designer steroids designed to 
    elude detection. Recent findings: Today any new designer steroid must 
    demonstrate both safety and effectiveness for the intended use. Although 
    new androgen formulations allow safer and more physiologic delivery, future 
    development will allow tissue selective therapies, such as bone or muscle. 
    One promising new area of development includes selective androgen receptor 
    modulators. Summary: Clinicians must understand the role of androgenic 
    anabolic steroids in clinical practice to provide patient care. Future 
    development of non-steroidal compounds - selective androgen receptor 
    modulators - will perhaps provide safer and more effective therapy. The 
    development of these new drugs must be watched. (c) 2006 Lippincott 
    Williams & Wilkins. 
      Copyright 2006 Elsevier B.V., All rights reserved. 
     
  /TN,TN=  BRAND NAME/MANUFACTURER NAME: bms 564929/ Bms ; kgd 2226/ligan; s 40503/ 
    Koken/Japan; equi gan; equipoise; masteron; maxibolin; halotestin; ora 
    testryl; ultradren; primobolan; dianabol; oreton; neo hombreol; metandren; 
    laurabolin; deca durabolin;  anavar ;  androl 50 ; winstrol; delatestryl; 
    perandren 
  /MN,MN=  MANUFACTURER NAMES:  Bms ; ligan; Koken/Japan 
  /DE  DESCRIPTORS: 
    *drug indication; *steroid; *anabolic agent 
    drug safety; drug efficacy; doping; athlete; patient care; review; illicit 
    drug; androgen; androgen receptor; boldenone; boldenone undecenoate; 
    drostanolone; ethylestrenol; metenolone enantate; metandienone; nandrolone 
    laurate; nandrolone decanoate; oxandrolone; stanozolol; oxymetholone; 
    testosterone enantate; testosterone propionate; fluoxymesterone; propionic 
    acid derivative; hydantoin; quinolone derivative; quinoline derivative; 
    unclassified drug; drostanolone propionate; metenolone acetate; 
    methyltestosterone 
  /ID  TERMS (UNCONTROLLED): ostarine; andarine; bms 564929; kgd 2226; s 40503; 
    equi gan; ultradren; androl 50 
     


BASIC INDEX [top]

SEARCH
SUFFIX		 DISPLAY
CODE		 FIELD NAME
 INDEXING
 SELECT EXAMPLES
None None All Basic Index Fields Word S ANDROGEN(W)RECEPTOR
/AB AB Abstract1 Word S NON(W)STEROIDAL/AB
/DE DE Descriptor (All)2 Word
& Phrase		 S DRUG(W)INDICATION/DE
S PATIENT CARE/DE
/ID ID Identifier3 Word
& Phrase		 S OSTARINE/ID
S ANDROL 50/ID
/MD MD Device Manufacturer4 Word
& Phrase		 S MACROPORE(W)BIOSURG?/MD
S MACROPORE BIOSURG?/MD
/MN MN Drug Manufacturer4 Word
& Phrase		 S BRISTOL(W)MYERS/MN
S BRISTOL MYERS?/MN
/ND ND Device Name4 Word
& Phrase		 S HYDROSORB(W)TS/ND
S HYDROSORB TS/ND
/TI TI Title Word S DESIGNER(W)STEROIDS/TI
/TN TN Drug Brand Name4 Word
& Phrase		 S BMS(W)564929/TN
S BMS 564929?/TN

1 Abstracts included for approximately 75% of the records.

2 Also /DF.

3 Also /IF. The Identifier field contains EMTREE terms.

4 Searchable in the Basic Index and in the Additional Indexes.


ADDITIONAL INDEXES [top]

SEARCH
PREFIX		 DISPLAY
CODE		 FIELD NAME
 INDEXING
 SELECT EXAMPLES
AA= AA EMBASE ID Number Phrase S AA=43731839
AU= AU Author Phrase S AU=FOURCROY J.
None AZ DIALOG Accession Number
CD= CD CODEN Phrase S CD=CENDE
CP= CP Country of Publication Word
& Phrase		 S CP=(UNITED(W)STATES)
S CP=UNITED STATES
CS= CS Corporate Source Word
& Phrase		 S CS=(FOURCROY(F)BETHESDA)
S CS=J. FOURCROY?
DT= DT Document Type Phrase S DT=JOURNAL
None EL Author E-mail
II= II Publisher Item Identifier Phrase S II=0006079320060600000012
JN= JN Journal Name Phrase S JN=CURRENT OPINION IN ENDOCRIN?
LA= LA Language Phrase S LA=ENGLISH
LT= None Limit Type: Animal Subject5 Phrase S LT=ANIMAL
MD= MD Device Manufacturer4 Word
& Phrase		 S MD=(MACROPORE(W)BIOSURGERY)
S MD=MACROPORE BIOSURGER?
MN= MN Drug Manufacturer4 Word
& Phrase		 S MN=(BRISTOL(W)MYERS(W)SQUIBB)
S MN=BRISTOL MYERS SQUIBB?
ND= ND Device Name4 Word
& Phrase		 S ND=(HYDROSORB(W)TS)
S ND=HYDROSORB TS
NO= NO Article Number Phrase S NO=10
PD= PD Publication Date Phrase S PD=20060111
PY= PY Publication Year Phrase S PY=2006
None RF Number of References
SL= SL Summary Language Phrase S SL=ENGLISH
SN= SN International Standard Serial Number (ISSN) Phrase S SN=1068-3097
SO= SO Source Information6 Word S SO=(CURRENT(W)OPINION(F)DIABE?)
SQ= SQ Molecular Sequence Number Phrase S SQ=N21294
TL= TL Clinical Trials Number Phrase S TL=NCT00342745
TN= TN Drug Brand Name4 Word
& Phrase		 S TN=(BMS(W)564929)
S TN=KGD 2226?
UD= None Update Phrase S UD=9999

5 To Limit to Animal Subjects, S S1 AND LT=ANIMAL

6 Display includes Journal Name, Volume, Issue, Pagination, and Publication Date.


LIMIT [top]

Sets and terms may be limited by Basic Index suffixes, i.e., /AB, /DD, /DE, /DF, /DM, /GS, /ID, /IF, /MN, /SH, /TI, /TN (e.g., S S5/DE), as well as by the following features:
SUFFIX FIELD NAME EXAMPLES
/ABS Abstract Present S ASTHMA/ABS
/ENG English Language S S4/ENG
/HUMAN Human Subject S COMPARATIVE STUDY/HUMAN
/MAJ Major Descriptor S VACCINE/MAJ
/NOABS No Abstract Present S S7/NOABS
/NONENG Non-English Language S STEM CELL/NONENG
/YYYY Publication Year S S8/2005:2006


SORT [top]

SORTABLE FIELDS EXAMPLES
AU, CS, JN, PD, PY, TI SORT S2/ALL/AU
SORT S4/ALL/PY,D


RANK [top]

RANK FIELDS EXAMPLES
All phrase- and numeric-indexed fields in the Additional Indexes can be ranked. Other RANK codes include: DE, ID RANK DE S3
RANK AU S4


USER-DEFINED FORMAT OPTIONS [top]

User-defined formats may be specified using the display codes indicated in the Search Options tables. TYPE S3/AU,TI,SO/1-5
PRINT S1/AU,AB/ALL


PREDEFINED FORMAT OPTIONS [top]

NO.
 DIALOGWEB
FORMAT		 RECORD CONTENT
1 -- DIALOG Accession Number
2 -- Full Record except Abstract
3 Medium Bibliographic Citation
4 -- Full Record with Tagged Fields1
5 -- Full Record1
6 Free Title and Publication Year
7 Long Bibliographic Citation and Abstract1
8 Short Title, Indexing, and Publication Year
9 Full Full Record1
K -- KWIC (Key Word In Context) displays a window of text; may be used alone or with other formats


DIRECT RECORD ACCESS [top]

FIELD NAME EXAMPLES
DIALOG Accession Number TYPE 1889668/5
DISPLAY 1888823/AU,TI
PRINT 1390632/5


Rates [top]

Rates For File: EMCare®[45]
Cost per DialUnit:                 $5.19
Cost per minute:                   $1.22
ALERT (default)                    $9.20
ALERT (Monthly)                   $36.81
ALERT (Biweekly/twice a month)    $18.40
ALERT (Weekly)                     $9.20
ALERT (Daily)                  *   $9.20
ALERT (Calendar weekly)        *   $9.20
ALERT (Intraday)               *   $9.20
* = custom scheduled Alerts only

Format    Types   Prints
     1    $0.00    $0.00
     2    $2.16    $2.16
     3    $2.16    $2.16
     4    $2.16    $2.16
     5    $2.16    $2.16
     6    $0.00    $0.00
     7    $2.16    $2.16
     8    $0.00    $0.00
     9    $2.16    $2.16
KWIC95    $0.14       NA
KWIC96    $0.14       NA

REDIST/COPY Multiplier Table:

      Range      Multiplier
        1-2       1.00
       3-25       1.50
     26-100       3.00
    101-200       4.00
    201-500       6.00
   501-1000       8.00
 1001 or more    10.00

ARCHIVE Multiplier Table:

      Range      Multiplier
       1-25       1.50
     26-200       3.00
    201-500       6.00
   501-1000       8.00
 1001 or more    10.00
[top]


All contents Copyright © Thomson Reuters. All rights reserved.
If you have any questions about, problems with, or corrections for our Web site,
please contact Customer Service for assistance.